Your browser doesn't support javascript.
loading
Intratumoral OH2, an oncolytic herpes simplex virus 2, in patients with advanced solid tumors: a multicenter, phase I/II clinical trial.
Zhang, Bo; Huang, Jing; Tang, Jialin; Hu, Sheng; Luo, Suxia; Luo, Zhiguo; Zhou, Fuxiang; Tan, Shiyun; Ying, Jieer; Chang, Qing; Zhang, Rui; Geng, Chengyun; Wu, Dawei; Gu, Xiangyong; Liu, Binlei.
Afiliación
  • Zhang B; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Huang J; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China huangjingwg@163.com.
  • Tang J; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China.
  • Hu S; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Luo S; Department of Thoracic Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Luo Z; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.
  • Zhou F; Department of Clinical Oncology, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
  • Tan S; Department of Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • Ying J; Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, China.
  • Chang Q; Department of Abdominal Oncology, Institute of Cancer Research & Basic Medical Sciences of Chinese Academy of Sciences, Cancer Hospital of University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China.
  • Zhang R; Department of Ultrasound, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Geng C; Department of Ultrasound, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Wu D; Department of Ultrasound, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Gu X; Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Liu B; Binhui Biopharmaceutical Co., Ltd, Wuhan, China.
J Immunother Cancer ; 9(4)2021 04.
Article en En | MEDLINE | ID: mdl-33837053
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_skin_diseases Asunto principal: Herpesvirus Humano 2 / Virus Oncolíticos / Viroterapia Oncolítica / Neoplasias Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_skin_diseases Asunto principal: Herpesvirus Humano 2 / Virus Oncolíticos / Viroterapia Oncolítica / Neoplasias Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: China